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Prehospital intravenous fentanyl
administered by ambulance personnel: a
cluster-randomised comparison of two
treatment protocols
Kristian D. Friesgaard1,2*, Hans Kirkegaard1, Claus-Henrik Rasmussen3,4, Matthias Giebner3,
Erika F. Christensen5,6 and Lone Nikolajsen7
Abstract
Background: Prehospital acute pain is a frequent symptom that is often inadequately managed. The concerns of
opioid induced side effects are well-founded. To ensure patient safety, ambulance personnel are therefore provided
with treatment protocols with dosing restrictions, however, with the concomitant risk of insufficient pain treatment
of the patients. The aim of this study was to investigate the impact of a liberal intravenous fentanyl treatment
protocol on efficacy and safety measures.
Methods: A two-armed, cluster-randomised trial was conducted in the Central Denmark Region over a 1-year period.
Ambulance stations (stratified according to size) were randomised to follow either a liberal treatment protocol (3 μg/kg)
or a standard treatment protocol (2 μg/kg). The primary outcome was the proportion of patients with sufficient pan
relief (numeric rating scale (NRS, 0–10) < 3) at hospital arrival. Secondary outcomes included abnormal vital parameters
as proxy measures of safety. A multi-level mixed effect logistic regression model was applied.
Results: In total, 5278 patients were included. Ambulance personnel following the liberal protocol administered higher
doses of fentanyl [117.7 μg (95% CI 116.7–118.6)] than ambulance personnel following the standard protocol [111.5 μg
(95% CI 110.7–112.4), P = 0.0001]. The number of patient with sufficient pain relief at hospital arrival was higher in the
liberal treatment group than the standard treatment group [44.0% (95% CI 41.8–46.1) vs. 37.4% (95% CI 35.2–39.
6), adjusted odds ratio 1.47 (95% CI 1.17–1.84)]. The relative decrease in NRS scores during transport was less
evident [adjusted odds ratio 1.18 (95% CI 0.95–1.48)]. The occurrences of abnormal vital parameters were similar
in both groups.
Conclusions: Liberalising an intravenous fentanyl treatment protocol applied by ambulance personnel slightly
increased the number of patients with sufficient pain relief at hospital arrival without compromising patient
safety. Future efforts of training ambulance personnel are needed to further improve protocol adherence and
quality of treatment.
Trial registration: ClinicalTrials.gov (NCT02914678). Date of registration: 26th September, 2016.
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Background
Efficient analgesic treatment is fundamental to ensure
patient comfort and to facilitate transport from incident
site to hospital [1, 2]. Notwithstanding, several studies
have shown that acute pain remains insufficiently treated
in emergency settings, which may be even more frequent
in an austere and uncontrolled prehospital environment
[3, 4]. A recent prehospital investigation has reported a a
high prevalence of 43% for insufficient pain relief at
hospital arrival among trauma patients treated by experi-
enced physicians [5].
Intravenous opioids are the mainstay in the rapid relief
of severe acute pain, but side effects, such as sedation and
respiratory depression, cannot be overlooked [6–18]. Due
to patient safety, non-physician staff are therefore provided
with simple one-drug protocols with dosing restrictions,
however, with the potential risk of insufficient pain relief.
In a recent prehospital study including 2348 adults and ad-
olescents treated with intravenous fentanyl in a maximum
dose of 2 μg/kg by Danish ambulance personnel, we
showed that a substantial number of patients (58.4%) had
moderate to severe pain at hospital arrival. In the same
study, the frequency of abnormal vital parameters, as
proxy measures of opioid-induced serious adverse effects,
was low [19].
The aim of this study was therefore to explore the im-
pact of liberalising a standard treatment protocol from a
maximum dose of 2 μg/kg to an allowed maximum dose
of 3 μg/kg on the intensity of pain at hospital arrival. We
hypothesised that a larger proportion of patients would
experience sufficient pain relief with the liberal treat-
ment protocol. In addition, we examined the frequency
of abnormal vital parameters.
Methods
Study design
This study was a two-armed, open-label, cluster-ran-
domised controlled trial comparing the impact of a
standard and a liberal fentanyl treatment protocol on
efficacy and safety parameters.
Setting
The trial was conducted in the Central Denmark Region
over a one-year period from 1st October 2016 to 30th
September 2017. Sixty-six ambulances from 36 ambulance
stations provide the emergency medical service for the
1,300,000 inhabitants of Central Denmark Region, corre-
sponding to 22% of the Danish population. The Region
covers both rural and urban areas [20]. The prehospital
model is two-tiered with Emergency Medical Technicians
(EMTs) or Paramedics (PMs) doing ground ambulance
transport, and prehospital physicians/anaesthesiologists
being dispatched to potentially life-threatening conditions
in a rendezvous setup (e.g. in case of an opioid overdose
and need of advanced airway management). Few stations
in the Central Denmark Region also have nurse-manned
emergency care units that can be dispatched in cases
where physicians are unavailable [21].
All patient care recordings were either automatically
(peripheral oxygen saturation, blood pressure and pulse)
or manually (Glasgow Coma Scale (GCS)), respiratory
rate) entered into an electronic touchscreen-based pre-
hospital medical record by EMTs/PMs. Assessment of
pain intensity (numeric rating scale (NRS), 0–10) was
required according to protocol from before initiation of
fentanyl treatment and every 5–10min until hospital ar-
rival. Furthermore, each registration was logged with the
exact date and time combined with the title (EMT/PM/
physician/nurse) and unique user identification number
of the treating healthcare provider.
Population
The sample included all patients treated with intraven-
ous fentanyl by EMTs or PMs. We did not consider pa-
tients for analysis if: 1) prehospital physicians were
dispatched to the scene and/or were providers of treat-
ment, 2) they were treated by personnel other than
EMTs/PMs (nurses), 3) they had unregistered personal
civil registration numbers and 4) the same patient ap-
peared more than once in the inclusion period, in which
only the first case was included. Patients with pain
scores registered at both baseline and hospital arrival
were considered for the analysis of efficacy, and all
patients were considered for the analysis of safety.
Randomisation
Randomisation was performed at the ambulance station
level with allocation to either the standard treatment
protocol for intravenous fentanyl (max 2 μg/kg) or the
liberal treatment protocol (max 3 μg/kg). The 36 ambu-
lance stations were stratified into 5 levels based on the
average number of transports per month (level 1 (n = 8):
< 70 transports), level 2 (n = 12): 70–199 transports, level
3 (n = 8): 200–399 transports, level 4 (n = 4): 400–899
transports, and level 5 (n = 4): ≥ 900 transports). Each
type of treatment protocol was then randomly allocated
in a 1:1 ratio within each of the 5 levels. Randomisation
of ambulance stations was carried out by an impartial
statistician at Aarhus University using STATA version
13.1 (StataCorp, TX, USA).
Blinding
Once randomised, ambulance station leaders and personnel
were instructed to follow the assigned treatment protocol
throughout the study period and were thus not blinded.
Patients treated with intravenous fentanyl were unaware of
the treatment protocol applied.
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Intervention
A liberal fentanyl treatment protocol was implemented
in the ambulance stations allocated to the intervention
arm with a 2-month run-in period prior to study start
between 1st August 2016 and 30th September 2016. The
liberal treatment protocol allowed EMTs/PMs to adminis-
ter intravenous fentanyl at a maximum dose of 3 μg/kg,
with the first dose limited to 1.5 μg/kg. The new fentanyl
treatment protocol was implemented at the enrolled sta-
tions following standard operating procedures and thus
left to the discretion of the leaders of the enrolled ambu-
lance stations. For ambulance stations not allocated to the
new protocol, the maximum dose of fentanyl was 2 μg/kg
with the first dose limited to 1 μg/kg. The exact dosing of
fentanyl was decided by the EMT/PM on a μg/kg basis
considering patient characteristics such as comorbidity
and age.
Outcomes
Primary and secondary outcomes pertained to the pa-
tient level. The primary outcome was the proportion of
patients with sufficient pain relief at hospital arrival,
defined as an NRS equal to or below 3 [22]. As proxy
measures of safety, secondary outcomes included any
occurrence of abnormal vital parameters defined as fol-
lows: GCS < 15, respiratory rate < 10/min, peripheral
oxygen saturation < 90% and mean arterial pressure
(MAP) < 70 mmHg [calculated as ((2 x diastolic blood
pressure) + (systolic blood pressure))/3] [23]. To investi-
gate whether the mean cumulative dose of fentanyl
increased following change of protocol, fentanyl admin-
istration practices for each EMT/PM was assessed for a
one-year period prior to study start between 1st August
2015 and 31st July 2016.
Data analysis
Information regarding clinical outcomes was extracted
from the electronic medical record. Dispatch data on
prehospital time stamps and geographical information
on each transport were obtained from the technical soft-
ware used by the dispatch staff of the Emergency Med-
ical Communication Center [21]. Individual data linkage
across registries and exact information on age and sex
was enabled by each patient’s central personal registra-
tion number [24]. The Danish National Patient Registry
were used to obtain the patients’ primary hospital diag-
noses classified according to the Danish version of the
International Classification of Diseases, 10th revision
(ICD-10) [25] and to calculate a 10-year Charlson
Comorbidity Index (CCI) score [26, 27]. Primary hospital
diagnosis codes were considered reasonable for linkage
with electronic medical record data if patients were
admitted within 12 h of prehospital (EMCC) contact.
All statistical analyses were conducted using STATA ver-
sion 13.1 (StataCorp, TX, USA). Means with 95% confi-
dence intervals (CI) are included for continuous parametric
variables. Continuous nonparametric data are provided as
medians with interquartile ranges (IQR). Categorical and
binomial data are presented as numbers and proportions
with 95% CIs. A chi square test, unpaired or paired stu-
dents t-test or Mann-Whitney U-test is used for descriptive
statistics when appropriate. A multi-level mixed effect
logistic regression model was fitted on binary outcomes in
order to account for the potential correlation between
patients within the same cluster (i.e. patients nested within
EMT/PM and EMTs/PMs nested within ambulance sta-
tion). The highest cluster level was defined as 1) ambulance
station, followed by 2) EMT/PM and 3) the patient. For the
adjusted estimates of safety outcomes, the model could not
be fitted without removing the highest level of clustering.
The results are presented as unadjusted and adjusted odds
ratios (OR) with 95% CIs and patients treated with the
standard protocol as reference.
The covariates considered in the multivariate statistical
analyses are based on the existing literature and clinical
experience: age (restricted cubic splines) [5, 28–32], sex
(binary) [5, 31], CCI score (0, 1, 2, 3+) [33–35], underlying
cause of pain (binary) [28, 29, 36, 37] and patient time with
EMT/PM (logarithmic function of time) [29, 31, 32, 38].
On the EMT/PM cluster level, a mean cumulative dose of
fentanyl was added as a covariate, and the title of ambu-
lance personnel (EMT or PM) was used as a proxy meas-
ure of experience. Ambulance station size (categorical)
was added on the highest cluster level. Age and prehospital
patient time were categorised as above to ensure the best
statistical model fit. The underlying cause of pain was
defined by primary hospital discharge codes (ICD-10), and
patients were stratified according to ICD-10 chapter 19
(injury, poisoning, and certain other consequences of
external causes (yes/no)).
To handle potential differences in baseline pain in-
tensity [5, 28–32, 39] between the standard and the lib-
eral treatment group, we assessed the relative (%)
change in NRS from baseline to hospital arrival in a
supplemental post-hoc analysis. The relative change in
pain scores during ambulance transport was assessed
with a multilevel mixed effect ordinal logistic regression
model [40], using the same cluster levels and covariates
as described above.
Sample size
We used a previous study from the same prehospital set-
ting and with a similar patient population treated with
intravenous fentanyl by EMTs/PMs as reference, in
which 42% achieved NRS ≤ 3 at hospital arrival [19].
With a fixed number of clusters (36 ambulance stations),
an intracluster correlation at 0.05 [41], 90% power and
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an alpha level at 5%, at least 1980 patients in each arm
would be required in order to identify a 10% points
increase in patients with sufficient pain relief (NRS ≤ 3)
at hospital arrival in the liberal pain treatment protocol
compared to the standard pain treatment protocol. The
data analyses are based on complete cases and include no
imputation for missing data. Two-sided tests with P values
< 0.05 were considered statistically significant.
Ethics
The study was approved by the Danish Data Protection
Agency (no. 1-16-02-294-16) and the National Board
of Health (no. 3-3013-2002/1). The local ethics com-
mittee was consulted, and the study was approved with
a waiver of patient consent. The trial was registered at
ClinicalTrials.gov (NCT02914678).
Results
Patient flow is presented in Figs. 1 and 2 gives an im-
pression of how patients are grouped in clusters. A total
of 2598 patients were treated with the standard treat-
ment protocol and 2680 patients were treated with the
liberal treatment protocol. No major differences in base-
line characteristics of patients were seen (Table 1). As
regards the primary outcome, the proportion of patients
who had sufficient pain relief at hospital arrival was
higher in the liberal treatment group than in the stand-
ard treatment group [44.0% (95% CI 41.8–46.1) vs.
37.4% (95% CI 35.2–39.6), P = 0.001] (Table 2). Taking
covariates and unobserved intracluster correlations into
account, the difference remained significant [OR 1.47
(95% CI 1.17–1.84)] (Table 3). In the supplemental
post-hoc analysis, there was no difference in the relative
decrease in pain scores during transport [43.0% (95% CI
41.3–44.7) vs. 40.5% (95% CI 39.0–42.1)] with an
adjusted OR equal to 1.18 (95% CI 0.95–1.48). No ap-
parent differences in the occurrence of abnormal vital
parameters were found (Tables 2 and 3) and none of the
patients were treated with an antidote (naloxone). A
similar number of patients in each group received an
Fig. 1 Flowchart for included patients. Abbreviations: EMTs; Emergency Medical Technicians, PMs, Paramedics, NRS; Numeric Rating Scale,
adm.; administration
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anti-emetic (ondansetron) [4.9% (95% CI 4.1–5.8) vs.
4.1% (95% CI 3.4–4.9), P = 0.15].
The mean cumulative dose of fentanyl administered by
EMTs/PMs in the liberal protocol was slightly higher than
that of the standard protocol [117.7 μg (95% CI 116.7–
118.6) vs. 111.5 μg (95% CI 110.7–112.4), P = 0.0001]. In
the one-year period before the protocol change.
no difference existed between the two groups com-
pared [106.7 μg (95% CI 105.7–107.7) vs. 108.0 μg (95%
CI 107.0–109.0), P = 0.09]. Higher doses were given in
the liberal treatment group for the patients not having
sufficient pain relief (NRS > 3) at hospital arrival than in
the standard treatment group [136.3 μg (95% CI 131.9–
140.8) vs. 126.9 μg (95% CI 123.0–130.7) (P = 0.001)]
(Table 2).
A considerable number of patients in both groups had
missing pain scores [liberal: 22.7 (95% CI 21.1–24.3) vs.
standard: 27.8 (95% CI 26.1–29.5), P = 0.001]. Character-
istics of patients with missing pain scores are presented
in Table 4. Generally, patients with missing pain scores
were older, more comorbid, lower initial pain scores,
and received lower doses of fentanyl compared with pa-
tients with complete information on pain scores. For the
patients with missing pain scores, no differences in pa-
tient characteristics were observed between the standard
treatment group and the liberal treatment group.
Discussion
In this large two-armed, cluster-randomised controlled
trial we found that patients treated with a liberal proto-
col were more likely to have sufficient pain relief at
hospital arrival than patients treated with a standard
treatment protocol. It can be argued that the difference
was small, and the question remains why more than half
the patients had insufficient pain relief, even with a lib-
eralised protocol. The explanation may be found in the
conservative doses of administered fentanyl, which again
may reflect concerns of malingering patients, apprehen-
sion of inducing side effects, and worries about blurring
symptoms and further diagnostics [42, 43]. The same
concerns may have arisen in other prehospital studies in
which higher doses (120–220 μg) were only obtained
Fig. 2 Map of Central Denmark Region with the clusters of included patients. Orange dots = Patients treated according to the standard treatment
protocol (max 2 μg/kg). Green dots = Patients treated according to the liberal treatment protocol (max 3 μg/kg)
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when administered by physicians or Australian/Ameri-
can paramedics without dosing restrictions (Table 5).
No differences in the occurrence of abnormal vital pa-
rameters were observed between the two groups and
none of the patients were given naloxone, which sug-
gests that EMTs/PMs can safely administer fentanyl in
a liberalised protocol.
Few other randomized controlled trials on prehospital
analgesia for adults have been conducted including small
samples ranging from 24 to 312 patients. Similar to our
study, two randomised controlled trials have investigated
the impact of increasing the opioid doses on analgesic
efficacy and safety. Woollard et al. investigated 172 pre-
hospital patients with diverse aetiologies of pain. The re-
searchers found that a rapid administration regiment
leading to higher cumulative doses (14.8 mg) of intraven-
ous nalbuphine (a semi-synthetic opioid) was more
effective than a cautious regiment (10.7 mg) with a lower
dose (ΔNRS: 4.29 units vs. 3.49 units, P = 0.028). In
terms of side effects, a higher frequency of drowsiness in
the patients treated with the rapid regiment was
observed [44]. Bounes et al. reached the opposing con-
clusion in a study on 106 prehospital patients with acute
pain, finding no superior analgesic effect or difference in
safety parameters for a higher fixed dose of intravenous
morphine compared to a lower fixed dose (absolute
doses not given) [10].
Other studies have compared newer synthetic opioids
with intravenous morphine. Smith et al. investigated 204
trauma patients in a physician-staffed helicopter and
found no difference in analgesic effect, occurrence of ab-
normal vital parameters or adverse effects when compared
with intravenous fentanyl [6]. A smaller physician-based
study on a diverse sample of 60 patients in France demon-
strated no difference between intravenous fentanyl and
morphine in terms of efficacy, vital sign abnormalities and
mild adverse effects [7]. Attempting to find a faster onset
of action for intravenous fentanyl in 207 patients with is-
chemic type chest pain, Weldon et al. found no analgesic
superiority compared with intravenous morphine. Also,
no differences in vital signs or adverse effects was found
[12]. Another small study of 36 patients with ischemic
type chest pain found more rapid onset and more effective
pain relief of intravenous alfentanil than intravenous
Table 1 Baseline characteristics of included patients
Treatment protocol Standard (2 μg/kg)
(n = 2598)
Liberal (3 μg/kg)
(n = 2680)
Age, years (95% CI) 56.3 (55.4–57.2) 56.9 (56.0–57.7)
Male sex, % (95% CI) 45.4 (43.5–47.3) 48.1 (46.2–50.0)
CCI score, % (95% CI)
0 59.7 (57.7–61.6) 56.9 (55.0–58.8)
1 14.9 (13.5–16.3) 15.0 (13.7–16.4)
2 10.0 (8.9–11.2) 10.9 (9.7–12.1)
3+ 15.4 (14.1–16.9) 17.2 (15.7–18.6)
Primary hospital diagnosis code (ICD-10) chapter 19 (injury), % (95% CI):
Yes 50.3 (48.3–52.2) 47.8 (45.9–49.7)
Cum. dose (μg) fentanyl,
mean (95% CI)
111.5 (110.7–112.4) 117.7 (116.7–118.6)
Treated by paramedic,
% (95% CI)
9.2 (8.1–10.4) 7.4 (6.4–8.4)
Patient recruitment according tostation size (transports/month), % (95% CI):
< 70 4.4 (3.6–5.1) 7.4 (6.1–8.1)
70–199 14.8 (13.5–16.1) 12.6 (11.4–13.8)
200–399 23.5 (21.8–25.0) 22.0 (20.2–23.2)
400–899 18.7 (17.1–20.1) 29.4 (27.6–30.9)
≥ 900 38.6 (36.8–40.5) 28.6 (26.3–30.3)
Time in ambulance
(minutes), median (IQR):
46 (34–61) 47 (36–61)
Abbreviations: CI confidence interval, CCI Charlson Comorbidity Index, ICD-10
10th version of the International Classification of Diseases, Cum. cumulative,
IQR interquartile range
Table 2 Pain scores and vital parameters of included patients
Treatment protocol Standard
(2 μg/kg)
Liberal
(3 μg/kg)
Pain characteristics for patients
with complete pain scores:
n = 1884 n = 2082
Pain, NRS score (mean, 95% CI):
Before treatment initiation 7.59 (7.50–7.67) 7.45 (7.36–7.54)
At hospital arrival 4.36 (4.26–4.46) 4.08 (3.98–4.17)
NRS ≤ 3 at hospital arrival, n:
No 1180 1167
Yes 704 915
NRS ≤ 3 at hospital arrival,
% (95% CI)
37.4 (35.2–39.6) 44.0 (41.8–46.1)
Difference, ΔNRS (95% CI):
Absolute decrease, units 3.23 (3.12–3.34) 3.37 (3.27–3.48)
Relative decrease, % 40.5 (39.0–42.1) 43.0 (41.3–44.7)
Cum. dose (μg, mean 95%CI) fentanyl and:
NRS ≤ 3 at hospital arrival 102.9 (98.4–107.3) 105.9
(102.4–109.4)
NRS ≥ 4 at hospital arrival 126.9
(123.0–130.7)
136.3
(131.9–140.8)
Characteristics of vital parameters
for all included patients:
n = 2598 n = 2680
GCS < 15, n (%): 68 (2.7) 69 (2.6)
Respiratory rate < 10/min, n (%): 9 (0.3) 10 (0.4)
Oxygen saturation < 90%, n (%): 547 (21.1) 608 (22.7)
MAP < 70 mmHg and decrease
≥ 10 mmHg, n (%):
182 (7.0) 199 (7.4)
Abbreviations: CI confidence interval, IQR interquartile range, Cum. cumulative,
NRS numeric rating scale (0–10), Δ: difference
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morphine and no differences in vital signs [13]. Investigat-
ing another fast-acting opioid, Bounes and colleagues
found no superior analgesic effect of intravenous sufenta-
nil compared to intravenous morphine for 108 trauma pa-
tients; in addition, vital signs and adverse effects were
similar [9]. Other randomised controlled trials have
assessed the impact of ketamine [45], combinations of
morphine and ketamine [8, 11] or other combinations [46,
47] or regional nerve blockades [48, 49]. Most of the trials
have been inconclusive, underpowered and with varying
levels of quality, which probably reflect the jurisdictional
and practical challenges of conducting research in an aus-
tere prehospital environment [50]. For the studies demon-
strating analgesic superiority [8, 11, 13, 44], the frequency
of adverse effects was also higher, so neither specific con-
clusions nor recommendations can be made. Few other
non-randomised (before-after) trials have sought to opti-
mise prehospital pain management by modifying existing
practice and educating the involved healthcare providers.
These studies all found insignificant changes in pain
scores, pain score documentation, and/or the cumulative
opioid doses provided [35, 51–57].
Strengths and limitations
The strengths of this two-armed, cluster-randomised con-
trolled trial rest on the large sample size and the
real-world population-based prehospital data individually
merged with validated national registries [24, 25]. We mit-
igated the risk of unobserved secular effects on estimates
by adding a non-historical control group and adopting a
pragmatic, cluster-randomised design, reflecting a real-life
Table 3 Odds ratios for differences in effect and safety
measures
Odds ratio (95% CI) P-value
Crude Adjusteda
NRS ≤ 3 at hospital arrival:
Standard 1 (reference) 1 (reference) 0.001
Liberal 1.42 (1.13–1.80) 1.47 (1.17–1.84)
NRS decrease (relative) during transport:
Standard 1 (reference) 1 (reference) 0.14
Liberal 1.15 (0.90–1.46) 1.18 (0.95–1.48)
GCS < 15:
Standard 1 (reference) 1 (reference) 0.76
Liberal 0.87 (0.27–2.80) 0.84 (0.27–2.62)
Respiratory rate < 10/min:
Standard 1 (reference) 1 (reference) 0.85
Liberal 1.07 (0.37–3.09) 1.11 (0.40–3.09)
Oxygen saturation < 90%:
Standard 1 (reference) 1 (reference) 0.15
Liberal 1.19 (0.96–1.47) 1.17 (0.95–1.44)
MAP < 70mmHg and decrease ≥ 10 mmHg:
Standard 1 (reference) 1 (reference) 0.96
Liberal 1.08 (0.74–1.57) 1.01 (0.70–1.47)
Abbreviations: CI confidence interval, NRS numeric rating scale, GCS Glasgow
Coma Scale, MAP mean arterial pressure, EMT emergency medical technician,
PM paramedic
a: Adjusted for age, sex, comorbidity, etiology (injury yes/no), time in
ambulance, station size, ambulance personnel experience (EMT or PM) and
mean dose administered by ambulance personnel. For vital parameters, the
highest cluster level (ambulance station) has been removed in the adjusted
analyses to ensure better model fit
Table 4 Characteristics of patients with and without complete pain scores
Treatment protocol Patients with missing pain scores Patients with complete pain scores
Standard (2 μg/kg)
(n = 714)
Liberal (3 μg/kg)
(n = 598)
Standard (2 μg/kg)
(n = 1884)
Liberal (3 μg/kg)
(n = 2088)
Age, years (95% CI) 59.5 (57.7–61.2) 60.7 (58.7–62.7) 55.1 (54.1–56.1) 55.8 (54.8–56.7)
Male sex, % (95% CI) 43.7 (40.0–47.4) 45.8 (41.7–49.9) 46.0 (43.7–48.3) 48.8 (46.6–50.9)
CCI score, % (95% CI)
0 55.2 (51.4–58.9) 52.0 (47.9–56.1) 61.4 (59.1–63.6) 58.4 (56.2–60.5)
1 17.6 (14.9–20.6) 16.7 (13.8–20.0) 13.9 (12.3–15.5) 14.6 (13.1–16.1)
2 9.4 (7.3–11.8) 11.4 (8.9–14.2) 10.2 (8.9–11.7) 10.7 (9.5–12.2)
3+ 17.8 (15.0–20.8) 19.9 (16.8–23.3) 14.5 (13.0–16.2) 16.3 (14.8–18.0)
Time in ambulance (minutes),
median (IQR):
44 (32–59) 48 (36–61) 47 (35–62) 47 (36–61)
Cum. dose (μg) fentanyl,
mean (95% CI)
96.7 (92.3–101.0) 99.3 (94.6–104.0) 117.9 (114.9–120.9) 122.9 (119.9–125.9)
Initial NRS scorea (mean, 95% CI): 6.52 (6.24–6.79) 6.21 (5.91–6.51) 7.59 (7.50–7.67) 7.45 (7.36–7.54)
Abbreviations: CCI Charlson Comorbidity Index, Cum. cumulative, NRS numeric rating scale
aGiven for the patients with an initial pain score but not a subsequent pain score at hospital arrival, which accounts for 307 patients in the standard group and
292 in the liberal group
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delivery of intervention. We undertook a stratified
randomisation in order to mitigate the risk of unbal-
anced patient samples and cluster-specific characteris-
tics at the ambulance station level. However, the
study also has a number of limitations that need to
be addressed.
First of all, similar to other prehospital investigations
into pain management, pain scores were missing in our
study (up to 27.8%) and this may have introduced bias.
Depending on study design and patient selection, the
proportion of patients with missing pain data in other
prehospital studies ranges from 15% [58], 25–35% [5, 28,
35, 36, 38], 40–60% [30, 59–61] to 70–80% [52, 62].
Missing data on pain scores impose a potential threat
to the validity of the findings and should be taken
into account when interpreted. We presented charac-
teristics of patients with and without pain scores and
found that patients with incomplete pain scores were
older, had more comorbidities and received lower
doses of fentanyl.
Second, the implementation of the liberal protocol was
left to the discretion of the enrolled ambulance station
leaders. This approach thus reflects the effect of protocol
changes when implemented in real-life settings but may
also partly explain the relatively small difference ob-
served between the groups.
Third, our study was probably not powered to detect
small differences on abnormal vital parameters as proxies
of adverse effects, as these events are infrequent, and
therefore a risk of type II errors exists. As the most
conservative example, 7093 patients in each arm would
have been required in order to find an occurrence of
hypotension of 3% among patients treated under the
standard protocol compared to 4% among patients treated
under the liberal treatment protocol.
Last, the occurrence of fentanyl side effects can be dif-
ficult to quantify precisely with discrete measures.
Exemplified by respiratory depression, hypoxemia may
very well be correlated with oxygenation as measured by
pulse oximetry when patients are breathing at atmos-
phere oxygen levels. However, it will be affected by
factors such as supplemental oxygen therapy or periph-
eral vasoconstriction [63]. The presence or absence of
abnormal vital parameters should therefore be inter-
preted in the light of these precautions.
Conclusion
Liberalising an intravenous fentanyl treatment proto-
col applied by EMTs/PMs resulted in slightly more
patients having sufficient pain relief at hospital arrival
compared to patients treated under a standard treat-
ment protocol. Fentanyl doses were conservatively ad-
ministered in both groups and the high overall
proportion of patients with insufficient pain relief
suggests that more should be done to ensure protocol
adherence. No differences in the occurrence of abnor-
mal vital parameters were observed between the two
groups, suggesting that future efforts in optimising
intravenous fentanyl protocols for non-physician staff
can be made safely under ongoing evaluation and
monitoring of the patients.
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